Aminobenzoic acids and derivatives
Aobchem 2-Methoxy-4 5-dimethylbenzoic acid | ≥97% | CAS 91061-36-8 | C10H12O3 | 250mg
2-Methoxy-4 5-dimethylbenzoic acid | ≥97% | CAS 91061-36-8 | C10H12O3 | 250mg
Aobchem 3-Fluoro-2 5-dimethylbenzoic acid | ≥97% | CAS 1427433-77-9 | C9H9FO2 | 250mg
3-Fluoro-2 5-dimethylbenzoic acid | ≥97% | CAS 1427433-77-9 | C9H9FO2 | 250mg
Chemscene Naphthalen-1-ylmethanamine | 100g | CS-W010910 | 98% | 118-31-0 | MFCD00004048 | 157 22 | C11H11N
Chemscene | Naphthalen-1-ylmethanamine | 100g | CS-W010910 | 98% | 118-31-0 | MFCD00004048 | 157 22 | C11H11N
Chemscene trans trans-4-(3 4-Difluorophenyl)-4 -pentyl-1 1 -bi(cyclohexane) | 100g | CS-W009815 | 98% | 118164-51-5 | MFCD13182310 | 348 52 | C23H34F2
Chemscene | trans trans-4-(3 4-Difluorophenyl)-4 -pentyl-1 1 -bi(cyclohexane) | 100g | CS-W009815 | 98% | 118164-51-5 | MFCD13182310 | 348 52 | C23H34F2
Aobchem 5-Amino-2-bromo-4-chlorobenzoic acid | ≥97% | CAS 1208077-55-7 | C7H5BrClNO2 | 250mg
5-Amino-2-bromo-4-chlorobenzoic acid | ≥97% | CAS 1208077-55-7 | C7H5BrClNO2 | 250mg
Aobchem 2-Chloro-4 5-dimethylbenzoic acid | ≥95% | CAS 15089-74-4 | C9H9ClO2 | 250mg
2-Chloro-4 5-dimethylbenzoic acid | ≥95% | CAS 15089-74-4 | C9H9ClO2 | 250mg
Aobchem 5-Amino-2-bromo-4-chlorobenzoic acid | ≥97% | CAS 1208077-55-7 | C7H5BrClNO2 | 1g
5-Amino-2-bromo-4-chlorobenzoic acid | ≥97% | CAS 1208077-55-7 | C7H5BrClNO2 | 1g
Medchemexpress LLC Purinostat mesylate | 2650188-32-0 | 99.45% | 586.62 | 100 MG
Purinostat mesylate is a selective inhibitor of HDAC, inhibiting class I and class IIb HDACs. It induces apoptosis, affects the cell cycle, and exhibits potent anti-leukemia effects in vivo, making it suitable for research on lymphoblastic leukemia.
- Selective inhibitor of HDACs
- Inhibits class I and class IIb HDACs (IC50s 0.81 to 11.5 nM)
- Induces apoptosis
- Affects cell cycle of LAMA84 and 188 BL-2 cells
- Exhibits potent anti-leukemia effects in vivo
- Suitable for research on lymphoblastic leukemia
- High purity: 99.45%
eMolecules 138-14-7 | Deferoxamine Mesylate | Ambeed | MFCD00058605 | 656.790 | C26H52N6O11S | 98.000 | CS(O)(=O)=O.CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN | 5g | 600851356
Deferoxamine Mesylate | Ambeed | 138-14-7 | MFCD00058605 | 656.790 | C26H52N6O11S | 98.000 | CS(O)(=O)=O.CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN | 5g | 600851356
Medchemexpress LLC Pamufetinib mesylate | 1688673-09-7 | 99.2% | 614.66 g·mol-1 | C28H27FN4O7S2 | 10MM 1ML
Pamufetinib mesylate is the methanesulfonate salt of a small-molecule kinase inhibitor that targets VEGFR and hepatocyte growth factor receptor (c-Met/HGFR). Supplied as a 10 mM solution in DMSO (1 mL) for in vitro research use, it demonstrates potent activity with reported IC50 values of 30 nM (rVEGFR2) and 32 nM (rMET). Molecular formula: C28H27FN4O7S2; molecular weight: 614.66 g·mol-1. Purity: 99.17%.
- Supplied as a ready-to-use 10 mM solution in DMSO.
- Suitable for in vitro kinase inhibition assays.
- Potent VEGFR and c-Met inhibitor with low-nanomolar IC50 values.
- High chemical purity (99.17%).
- For research use only; not for human or veterinary use.
Medchemexpress LLC KB-R7943 mesylate | 182004-65-5 | C17H21N3O6S2 | 50 MG
KB-R7943 mesylate is an inhibitor of the reverse Na+/Ca2+ exchanger (NCXrev) with an IC50 of 5.7±2.1 μM. It induces cancer cell death via JNK pathway activation and autophagic flux blockade. The compound also blocks NMDAR-mediated ion currents and inhibits NMDA-induced increases in cytosolic Ca2+. It can depolarize mitochondria and inhibit 2,4-dinitrophenol-stimulated respiration of cultured neurons. This product is a solid, white to yellow compound with a molecular weight of 427.50.
- Inhibits reverse Na+/Ca2+ exchanger (NCXrev).
- Activates JNK pathway and blocks autophagic flux to induce cancer cell death.
- Blocks NMDAR-mediated ion currents and inhibits NMDA-induced increases in cytosolic Ca2+.
- Depolarizes mitochondria and inhibits 2,4-dinitrophenol-stimulated respiration.
- Inhibits IhERG and native IKr.
- Solid form, white to yellow color, molecular weight of 427.50.
Medchemexpress LLC Safinamide mesylate | 202825-46-5 | 99.07% | C18H23FN2O5S | 1 ML
Safinamide mesylate is a potent, selective, and reversible monoamine oxidase B (MAO-B) inhibitor, blocking sodium channels and modulating glutamate (Glu) release. It demonstrates neuroprotective and neurorescuing effects, making it suitable for the study of Parkinson's disease and ischemic stroke.
- Potent, selective, and reversible monoamine oxidase B (MAO-B) inhibitor
- Blocks sodium channels
- Modulates glutamate (Glu) release
- Demonstrates neuroprotective and neurorescuing effects
- Used for the study of Parkinson's disease
- Used for the study of ischemic stroke
Medchemexpress LLC CP-506 mesylate | 2227304-19-8 | 98.6% | 681.60 | 1 MG
CP-506 mesylate (CAS 2227304-19-8) is a chemical compound with a molecular weight of 681.60. This compound, appearing as a light yellow to yellow solid, boasts a purity of 98.59%. It is provided for research use only, and has not been fully validated for medical applications.
- Purity of 98.59%
- Stable in powder form at -20°C for 3 years
- Stable in powder form at 4°C for 2 years
- Stable in solvent at -80°C for 6 months
- Stable in solvent at -20°C for 1 month
- Identified by CAS 2227304-19-8
Medchemexpress LLC Rasagiline (mesylate) | 161735-79-1 | 99.8% | 267.34 | 100 MG
Rasagiline mesylate is a highly potent selective irreversible mitochondrial monoamine oxidase (MAO) inhibitor. It is also described as a click chemistry reagent containing an Alkyne group that can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
- Highly potent selective irreversible mitochondrial monoamine oxidase (MAO) inhibitor
- IC50s of 4.43 nM for rat brain MAO B activity
- IC50s of 412 nM for rat brain MAO A activity
- Click chemistry reagent
- Capable of copper-catalyzed azide-alkyne cycloaddition
- Increases proliferation rates of certain cell lines
- Neuroprotective in a transgenic model of multiple system atrophy
Medchemexpress LLC Ibutamoren (Mesylate) | 159752-10-0 | C28H40N4O8S2 | 100 MG
Ibutamoren Mesylate (MK-677) is a potent, non-peptide Growth hormone secretagogue receptor (GHSR) agonist. It is an orally active growth hormone (GH) secretagogue, shown to increase serum IGF-1 and GH levels in vivo.
- Potent, non-peptide growth hormone secretagogue receptor (GHSR) agonist
- Orally active growth hormone (GH) secretagogue
- Increases serum IGF-1 and GH levels
- Increases peak GH concentrations after oral administration